[SCIENTX] YoY Annualized Quarter Result on 31-Jul-2016 [#4]

Stock
[SCIENTX] SCIENTEX BERHAD
Announcement Date
26-Sep-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2016
Quarter
31-Jul-2016 [#4]
Profit Trend
QoQ- -3.26%
YoY- 52.26%
Quarter Report
Latest QR
Upcoming QR
SCIENTX's Result
SCIENTX's Financial Summary
View:
Show?
Annualized Quarter Result
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
Revenue 3,247,446 2,626,767 2,403,151 2,200,980 1,801,684 1,590,472 1,229,045 17.57%
PBT 450,588 361,658 317,968 306,332 220,962 186,266 142,980 21.07%
Tax -104,680 -67,624 -58,027 -59,765 -58,866 -34,765 -30,483 22.81%
NP 345,908 294,034 259,941 246,567 162,096 151,501 112,497 20.57%
-
NP to SH 333,697 289,806 255,873 240,865 158,190 148,450 110,284 20.25%
-
Tax Rate 23.23% 18.70% 18.25% 19.51% 26.64% 18.66% 21.32% -
Total Cost 2,901,538 2,332,733 2,143,210 1,954,413 1,639,588 1,438,971 1,116,548 17.24%
-
Net Worth 2,225,929 1,765,024 1,527,344 1,162,467 936,606 712,170 613,649 23.94%
Dividend
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
Div 103,052 97,785 76,847 50,047 49,413 46,445 56,179 10.63%
Div Payout % 30.88% 33.74% 30.03% 20.78% 31.24% 31.29% 50.94% -
Equity
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
Net Worth 2,225,929 1,765,024 1,527,344 1,162,467 936,606 712,170 613,649 23.94%
NOSH 515,261 488,926 483,558 227,488 224,605 221,171 216,073 15.57%
Ratio Analysis
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
NP Margin 10.65% 11.19% 10.82% 11.20% 9.00% 9.53% 9.15% -
ROE 14.99% 16.42% 16.75% 20.72% 16.89% 20.84% 17.97% -
Per Share
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
RPS 630.25 537.25 500.35 967.51 802.15 719.11 568.81 1.72%
EPS 66.66 59.59 54.83 105.88 70.43 67.12 51.04 4.54%
DPS 20.00 20.00 16.00 22.00 22.00 21.00 26.00 -4.27%
NAPS 4.32 3.61 3.18 5.11 4.17 3.22 2.84 7.23%
Adjusted Per Share Value based on latest NOSH - 229,970
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
RPS 208.67 168.79 154.42 141.43 115.77 102.20 78.97 17.57%
EPS 21.44 18.62 16.44 15.48 10.16 9.54 7.09 20.24%
DPS 6.62 6.28 4.94 3.22 3.18 2.98 3.61 10.62%
NAPS 1.4303 1.1341 0.9814 0.747 0.6018 0.4576 0.3943 23.94%
Price Multiplier on Financial Quarter End Date
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
Date 31/07/19 31/07/18 31/07/17 29/07/16 31/07/15 31/07/14 31/07/13 -
Price 8.42 7.90 8.66 12.70 7.10 5.69 5.29 -
P/RPS 1.34 1.47 1.73 1.31 0.89 0.79 0.93 6.27%
P/EPS 13.00 13.33 16.26 11.99 10.08 8.48 10.36 3.85%
EY 7.69 7.50 6.15 8.34 9.92 11.80 9.65 -3.71%
DY 2.38 2.53 1.85 1.73 3.10 3.69 4.91 -11.36%
P/NAPS 1.95 2.19 2.72 2.49 1.70 1.77 1.86 0.79%
Price Multiplier on Announcement Date
31/07/19 31/07/18 31/07/17 31/07/16 31/07/15 31/07/14 31/07/13 CAGR
Date 26/09/19 20/09/18 19/09/17 26/09/16 29/09/15 24/09/14 26/09/13 -
Price 8.94 8.57 8.60 6.30 7.05 6.95 5.46 -
P/RPS 1.42 1.60 1.72 0.65 0.88 0.97 0.96 6.73%
P/EPS 13.80 14.46 16.14 5.95 10.01 10.35 10.70 4.32%
EY 7.24 6.92 6.19 16.81 9.99 9.66 9.35 -4.17%
DY 2.24 2.33 1.86 3.49 3.12 3.02 4.76 -11.80%
P/NAPS 2.07 2.37 2.70 1.23 1.69 2.16 1.92 1.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment